Global effects of mistranslation from an editing defect in mammalian cells.
暂无分享,去创建一个
[1] Manuel A. S. Santos,et al. Selective advantages created by codon ambiguity allowed for the evolution of an alternative genetic code in Candida spp. , 1999, Molecular microbiology.
[2] D. Yang,et al. Cloning, sequencing and expression of a cDNA encoding mammalian valyl-tRNA synthetase. , 1993, Gene.
[3] Paul Schimmel,et al. Mutational separation of two pathways for editing by a class I tRNA synthetase. , 2002, Molecular cell.
[4] R. Kopito,et al. Impairment of the ubiquitin-proteasome system by protein aggregation. , 2001, Science.
[5] M. J. Cormier,et al. Primary structure of the Aequorea victoria green-fluorescent protein. , 1992, Gene.
[6] W. Weigle. THE INDUCTION OF AUTOIMMUNITY IN RABBITS FOLLOWING INJECTION OF HETEROLOGOUS OR ALTERED HOMOLOGOUS THYROGLOBULIN , 1965, The Journal of experimental medicine.
[7] Fred E. Cohen,et al. Therapeutic approaches to protein-misfolding diseases , 2003, Nature.
[8] C. Dobson,et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.
[9] D. Kirschner,et al. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.
[10] Rune R. Frants,et al. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter , 2001, Nature Genetics.
[11] P. Marlière,et al. Enlarging the Amino Acid Set of Escherichia coli by Infiltration of the Valine Coding Pathway , 2001, Science.
[12] S. Martinis,et al. Molecular dissection of a critical specificity determinant within the amino acid editing domain of leucyl-tRNA synthetase. , 2004, Biochemistry.
[13] Patrick R. Griffin,et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.
[14] Hieronim Jakubowski,et al. Alternative pathways for editing non-cognate amino acids by aminoacyl- tRNA synthetases , 1981, Nucleic Acids Res..
[15] M. Snoek,et al. The sequence and organization of the mouse valyl-tRNA synthetase gene G7a/Bat6 located in the MHC class III region , 1999, Immunogenetics.
[16] M. Davisson,et al. ‘Wasted’, a new mutant of the mouse with abnormalities characteristic of ataxia telangiectasia , 1982, Nature.
[17] R. Campbell,et al. Evidence that gene G7a in the human major histocompatibility complex encodes valyl-tRNA synthetase. , 1991, The Biochemical journal.
[18] V. de Crécy-Lagard,et al. Inhibited cell growth and protein functional changes from an editing-defective tRNA synthetase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Ebel,et al. The yeast VAS1 gene encodes both mitochondrial and cytoplasmic valyl-tRNA synthetases. , 1988, The Journal of biological chemistry.
[20] P. Schimmel,et al. Formation of two classes of tRNA synthetases in relation to editing functions and genetic code. , 2001, Cold Spring Harbor symposia on quantitative biology.
[21] C. Abbott,et al. The lethal mutation of the mouse wasted (wst) is a deletion that abolishes expression of a tissue-specific isoform of translation elongation factor 1alpha, encoded by the Eef1a2 gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[22] H. Trachsel. Translation In Eukaryotes , 1991 .
[23] J. Trojanowski. Tauists, Baptists, Syners, Apostates, and new data , 2002, Annals of neurology.
[24] E. Goldman,et al. Editing of errors in selection of amino acids for protein synthesis. , 1992, Microbiological reviews.
[25] W. M. Westler,et al. Chemical structure of the hexapeptide chromophore of the Aequorea green-fluorescent protein. , 1993, Biochemistry.
[26] Rachel Green,et al. Fidelity in protein synthesis , 2005, Current Biology.
[27] M. Sternberg,et al. Enhanced genome annotation using structural profiles in the program 3D-PSSM. , 2000, Journal of molecular biology.
[28] C. Carter,et al. Cognition, mechanism, and evolutionary relationships in aminoacyl-tRNA synthetases. , 1993, Annual review of biochemistry.
[29] S. Ackerman,et al. Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration , 2006, Nature.
[30] A. Gow,et al. The unfolded protein response in protein aggregating diseases , 2007, NeuroMolecular Medicine.
[31] D Fischer,et al. CAFASP‐1: Critical assessment of fully automated structure prediction methods , 1999, Proteins.
[32] V. Döring,et al. Genetic Code Ambiguity , 2002, The Journal of Biological Chemistry.
[33] G. Bec,et al. Reconstitution in vitro of the valyl-tRNA synthetase-elongation factor (EF) 1 beta gamma delta complex. Essential roles of the NH2-terminal extension of valyl-tRNA synthetase and of the EF-1 delta subunit in complex formation. , 1994, The Journal of biological chemistry.
[34] D G Vassylyev,et al. Enzyme structure with two catalytic sites for double-sieve selection of substrate. , 1998, Science.
[35] M. Ibba,et al. Loss of Editing Activity during the Evolution of Mitochondrial Phenylalanyl-tRNA Synthetase* , 2005, Journal of Biological Chemistry.
[36] G. Bec,et al. Valyl-tRNA synthetase from rabbit liver. I. Purification as a heterotypic complex in association with elongation factor 1. , 1989, The Journal of biological chemistry.
[37] D. Perlmutter. The cellular response to aggregated proteins associated with human disease. , 2002, The Journal of clinical investigation.
[38] M. Mirande,et al. Functional Interaction of Mammalian Valyl-tRNA Synthetase with Elongation Factor EF-1α in the Complex with EF-1H* , 1999, The Journal of Biological Chemistry.
[39] Roger Y. Tsien,et al. Improved green fluorescence , 1995, Nature.
[40] S. Yokoyama,et al. Structural Basis for Non-cognate Amino Acid Discrimination by the Valyl-tRNA Synthetase Editing Domain* , 2005, Journal of Biological Chemistry.
[41] J. Thevelein,et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy , 2006, Nature Genetics.
[42] J. Sambrook,et al. Protein folding in the cell , 1992, Nature.
[43] E. Wang,et al. Characterization of Elongation Factor-1A (eEF1A-1) and eEF1A-2/S1 Protein Expression in Normal and wasted Mice* , 2001, The Journal of Biological Chemistry.
[44] William E. Balch,et al. Integration of endoplasmic reticulum signaling in health and disease , 1999, Nature Medicine.
[45] D. Yang,et al. Mammalian high molecular weight and monomeric forms of valyl-tRNA synthetase. , 1988, Biochemistry.
[46] Paul Schimmel,et al. Elucidation of tRNA‐dependent editing by a class II tRNA synthetase and significance for cell viability , 2003, The EMBO journal.
[47] M. S. van der Knaap,et al. Leukoencephalopathy With Vanishing White Matter: From Magnetic Resonance Imaging Pattern to Five Genes , 2003, Journal of child neurology.
[48] S. Zimmer,et al. Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis. , 2000, Anticancer research.
[49] Sunghoon Kim,et al. Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[50] N. Sonenberg,et al. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap , 1990, Nature.
[51] T. Fukuchi-Shimogori,et al. Malignant transformation by overproduction of translation initiation factor eIF4G. , 1997, Cancer research.
[52] D. Söll,et al. Aminoacyl-tRNA synthesis. , 2000, Annual review of biochemistry.
[53] A. Steinmetz,et al. Transfer RNAs and aminoacyl-tRNA synthetases in plant organelles. , 1980 .
[54] P. Schimmel,et al. Mutational analysis suggests the same design for editing activities of two tRNA synthetases. , 1996, Biochemistry.
[55] P. Lansbury,et al. Amyloid diseases: abnormal protein aggregation in neurodegeneration. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[56] P. Schimmel,et al. Transfer ribonucleic acid synthetase catalyzed deacylation of aminoacyl transfer ribonucleic acid in the absence of adenosine monophosphate and pyrophosphate. , 1972, Biochemistry.
[57] P. Marlière,et al. Artificially ambiguous genetic code confers growth yield advantage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[58] John Q Trojanowski,et al. ‘Unfolding’ pathways in neurodegenerative disease , 2003, Trends in Neurosciences.
[59] R. Kaufman. Orchestrating the unfolded protein response in health and disease. , 2002, The Journal of clinical investigation.
[60] W. Weigle. TERMINATION OF ACQUIRED IMMUNOLOGICAL TOLERANCE TO PROTEIN ANTIGENS FOLLOWING IMMUNIZATION WITH ALTERED PROTEIN ANTIGENS , 1962, The Journal of experimental medicine.
[61] M. Tuite,et al. The non‐standard genetic code of Candida spp.: an evolving genetic code or a novel mechanism for adaptation? , 1997, Molecular microbiology.
[62] S Falkow,et al. FACS-optimized mutants of the green fluorescent protein (GFP). , 1996, Gene.
[63] Roland L. Dunbrack,et al. Comparative modeling of CASP3 targets using PSI‐BLAST and SCWRL , 1999, Proteins.
[64] P. Schimmel,et al. Residues in a class I tRNA synthetase which determine selectivity of amino acid recognition in the context of tRNA. , 1995, Biochemistry.
[65] C. Kurland,et al. Translational accuracy and the fitness of bacteria. , 1992, Annual review of genetics.
[66] R B Loftfield,et al. The frequency of errors in protein biosynthesis. , 1972, The Biochemical journal.
[67] M. Yarus. Phenylalanyl-tRNA synthetase and isoleucyl-tRNA Phe : a possible verification mechanism for aminoacyl-tRNA. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[68] Paul Schimmel,et al. Incorporation of nonnatural amino acids into proteins. , 2004, Annual review of biochemistry.
[69] A. N. Baldwin,et al. Transfer ribonucleic acid-induced hydrolysis of valyladenylate bound to isoleucyl ribonucleic acid synthetase. , 1966, The Journal of biological chemistry.
[70] T. Steitz,et al. Insights into editing from an ile-tRNA synthetase structure with tRNAile and mupirocin. , 1999 .
[71] C. Anfinsen. Principles that govern the folding of protein chains. , 1973, Science.
[72] A. Wolfson,et al. Purification and properties of a high-molecular-mass complex between Val-tRNA synthetase and the heavy form of elongation factor 1 from mammalian cells. , 1991, European journal of biochemistry.
[73] K. Fischbeck,et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. , 2003, American journal of human genetics.